OncoGenex Increases Economic Interest in Lead Cancer Drug OGX-011 04 July 2008 Under the amended agreement between OncoGenex and Isis, the former will be solely responsible for all future development activities related to OGX-011.
MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 03 July 2008 Research conducted at the institute has contributed to a major licensing agreement signed between Bionomics and Merck Serono.
Bayer HealthCare and Maxygen Announce Hematology Agreement 03 July 2008 The $120 million transaction includes license to Maxygen’s novel biotechnology research platform.
Palatin Technologies Announces Amendment Expanding AstraZeneca Obesity Collaboration 02 July 2008 AstraZeneca and Palatin amend their collaboration agreement to discover, develop and commercialize compounds that target melanocortin receptors.
Galapagos Signs new Compound Management Agreement with Sepracor 01 July 2008 Under the terms of the agreement, BioFocus DPI will receive, register, and store selected compounds from Sepracor’s proprietary compound library.
Cellumen to Collaborate with the NCTR of the FDA to Apply Cellular Systems Biology to Predictive Toxicology 01 July 2008 Cellumen will use its proprietary CellCiphr® toxicity risk assessment technology to profile blinded samples of known liver toxicity compounds.
Millipore Unveils Expanded Drug Discovery Development Facility 30 June 2008 The $3.4 million expansion will enable Millipore to keep pace with the growth of its worldwide drug discovery and development business.
Eden Biodesign Confirms Research Triangle Park Facility 26 June 2008 The Company expands US operation to offer a range of cell line/strain development and early process development services.